Leandro Alegria Vieira

Leandro Alegria Vieira

Auto-generated profile, based on publicly available information

Leandro Alegria Vieira

Military Institute of Engineering (IME), Rio de Janeiro-RJ, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
MSMarcos Antonio Custódio Neto da Silva
Marcos Antonio Custódio Neto da Silva
JTJosiane Weber Tessmann
Josiane Weber Tessmann
KBKatia Regina Assuncão Borges
Katia Regina Assuncão Borges
LWLaís Araújo Souza Wolff
Laís Araújo Souza Wolff
FBFernanda Botelho
Fernanda Botelho
JCJoão Ernesto de Carvalho
João Ernesto de Carvalho
Açaí, Euterpe oleracea Mart., is a native plant from the Amazonian and is rich in several phytochemicals with anti-tumor activities. The aim was to analyze the effects of açaí seed oil on colorectal adenocarcinoma (ADC) cells. In vitro analyses were performed on CACO-2, HCT-116, and HT-29 cell lines. The strains were treated with açaí seed oil for 24, 48, and 72 h, and cell viability, death, and morphology were analyzed. Molecular docking was performed to evaluate the interaction between the major compounds in açaí seed oil and Annexin A2. The viability assay showed the cytotoxic effect of the oil in colorectal adenocarcinoma cells. Acai seed oil induced increased apoptosis in CACO-2 and HCT-116 cells and interfered with the cell cycle. Western blotting showed an increased expression of LC3-B, suggestive of autophagy, and Annexin A2, an apoptosis regulatory protein. Molecular docking confirmed the interaction of major fatty acids with Annexin A2, suggesting a role of açaí seed oil in modulating Annexin A2 expression in these cancer cell lines. Our results suggest the anti-tumor potential of açaí seed oil in colorectal adenocarcinoma cells and contribute to the development of an active drug from a known natural product.

8 January 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JAJoyce Almeida
Joyce Almeida
FBFernanda Botelho
Fernanda Botelho
FSFelipe Rodrigues Souza
Felipe Rodrigues Souza
MSMarcelo C. dos Santos
Marcelo C. dos Santos
Arlan GonçalvesArlan Gonçalves
Arlan Gonçalves
TFTanos Franca
Tanos Franca
The acute respiratory syndrome caused by the SARS-CoV-2, known as COVID-19, has been ruthlessly tormenting the world population for more than six months. However, so far no effective drug or vaccine against this plague have emerged yet, despite the huge effort in course by researchers and pharmaceutical companies worldwide. Willing to contribute with this fight to defeat COVID-19, we performed a virtual screening study on a library containing Food and Drug Administration (FDA) approved drugs, in a search for molecules capable of hitting three main molecular targets of SARS-CoV-2 currently available in the Protein Data Bank (PDB). Our results were refined with further molecular dynamics (MD) simulations and MM-PBSA calculations and pointed to 7 multi-target hits which we propose here for experimental evaluation and repurposing as potential drugs against COVID-19. Additional rounds of docking, MD simulations and MM-PBSA calculations with remdesivir suggested that this compound can also work as a multi-target drug against SARS-CoV-2. Communicated by Ramaswamy H. Sarma

4 March 2025 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
LBLeandro B. Bernardo
Leandro B. Bernardo
LVLeandro A. Vieira
Leandro A. Vieira
CBCaio V. N. Borges
Caio V. N. Borges
PBPedro A. G. Buitrago
Pedro A. G. Buitrago
Kamil KucaKamil Kuca
Kamil Kuca
DKDaniel Antonio Shimizu Kitagawa
Daniel Antonio Shimizu Kitagawa

11 September 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
LBLeandro Bernardo
Leandro Bernardo
LVLeandro Vieira
Leandro Vieira
CBCaio Borges
Caio Borges
PBPedro Buitrago
Pedro Buitrago
Kamil KucaKamil Kuca
Kamil Kuca
DKDaniel Antonio Shimizu Kitagawa
Daniel Antonio Shimizu Kitagawa
Recent events involving A-series nerve agents, a once elusive class of chemical warfare agents, have provoked a great concern in the international community. In this paper, continuing our research efforts in Medicinal Chemistry at IDQBRN, a OPCW Designated Laboratory for environmental samples, we explore ANMP, a A-230 surrogate, as an inhibitor, in the search for new treatment options for intoxication caused by these chemicals. We evaluated the potential of five isatin-pyridine oximes hybrids as reactivators using a modified Ellman’s assay. The results suggest that isatin-oxime monocationic hybrids structures with 5 methylene units and its oxa-analog could be promising for the design of new AChE reactivator.